当前位置: 首页 > 期刊 > 《中国医学创新》 > 2025年第20期
编号:2389157
丹参注射液治疗慢性肺源性心脏病失代偿期的效果及对血栓前状态标志物、心功能的影响
http://www.100md.com 2025年8月10日 中国医学创新 2025年第20期
     Effect of Danshen Injection in the Treatment of Decompensated Chronic Pulmonary Heart Disease and the Impact on Prethrombotic State Markers and Cardiac Function/FAN Lizhen, XIONG Jiangqin, XIONG Zhenni. //Medical Innovation of China,2025,22(20): 069-073

    [Abstract]Objective:To analyze the therapeutic efectof Danshen Injection on patients with decompensated chronic pulmonary heart disease (CPHD)and its influence on prethrombotic state markers and cardiac function. Method:A totalof 8O patients with decompensated CPHD who visited Jiangxi Chest Hospital from May 2023 to July 2024 were selected and divided into control group and treatment group according to the random number table method,with 4O cases ineach group.The control group was given conventional treatments suchas oxygen inhalation, cardiacstrengtheningand diuresis.The treatment group was treated with Danshen Injectiononthebasis of the control group.Both groups received continuous treatment for7days.The changes of coagulation function,hemorheological indicators and cardiac function measurement valuesbefore and after treatment inthe two groups were observed ......

您现在查看是摘要页,全文长 12986 字符